Dr. Mcdermott is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
Boston, MA 02115Phone+1 617-732-5500
Education & Training
Weill Cornell MedicineClass of 2015
Massachusetts General HospitalResidency, Internal Medicine
Certifications & Licensure
MA State Medical License 2017 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Rheumatology
Publications & Presentations
PubMed
- Safety of CAR T-cell therapy for cancer in pre-existing autoimmune or inflammatory disease: a retrospective comparative cohort study.Kathleen M M Vanni, Kaitlin R McCarter, Xiaosong Wang, Caitlyn Duffy, Jamie P Dela Cruz
The Lancet. Rheumatology. 2025-04-01 - Polygenic risk scores for rheumatoid arthritis and idiopathic pulmonary fibrosis and associations with RA, interstitial lung abnormalities, and quantitative interstiti...Gregory C McDermott, Matthew Moll, Michael H Cho, Keigo Hayashi, Pierre-Antoine Juge
Seminars in Arthritis and Rheumatism. 2025-03-15 - Tumour necrosis factor inhibitor safety in rheumatoid arthritis-associated interstitial lung disease.Gregory C McDermott, Jeffrey A Sparks
The Lancet. Rheumatology. 2025-03-01
Press Mentions
Do TNF Inhibitors Really Worsen RA-Associated Lung Disease?January 10th, 2025- RA-ILD in the Spotlight at ACR 2024 SaveNovember 26th, 2024
- ILD Subtypes in Rheumatoid Arthritis Carry Different Risk Factor ProfilesSeptember 27th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
